Derek Yoon
Directeur/Bestuurslid bij ARCELLX, INC.
Oorsprong van het eerstegraads netwerk van Derek Yoon
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Aju IB Investment Co., Ltd. (Private Equity)
 Aju IB Investment Co., Ltd. (Private Equity) Investment ManagersFinance Aju IB Investment Co., Ltd. (Aju IB) is the venture capital subsidiary of AJU Capital Co., Ltd founded in 1974 by Korea Technology Development Corp. The firm is headquartered in Seoul, Korea.
42
| Subsidiary | Investment Managers | 42 |
| Public Company | Biotechnology | 22 | |
Citizens Bank, NA (Providence, Rhode Island)
 Citizens Bank, NA (Providence, Rhode Island) Major BanksFinance Citizens Bank NA provides commercial banking services. It offers credit cards, borrowing services, student lending solutions, retirement plans, and wealth management and investment services. The company is headquartered in Providence, RI.
6
| Subsidiary | Major Banks | 6 |
Solasta Ventures, Inc.
 Solasta Ventures, Inc. Investment ManagersFinance Solasta Ventures Inc (Solasta Ventures) is a venture capital division of AJU IB Investment Co Ltd (South Korea) founded in 2019. The firm is headquartered in Boston, Massachusetts.
5
| Subsidiary | Investment Managers | 5 |
| Public Company | Pharmaceuticals: Major | 5 | |
Carbon Biosciences, Inc.
 Carbon Biosciences, Inc. Medical/Nursing ServicesHealth Services Carbon Biosciences, Inc. is a biotech company that is based in Boston, MA. The company is focused on expanding the therapeutic potential of gene therapy through its proprietary platform which leverages novel parvoviruses that have been pressure tested by nature to target specific tissues and carry a larger cargo with minimal neutralizing immunity and the potential to re-dose. The company is working to expand the gene therapy toolbox for the treatment of the world's most devastating and difficult to treat diseases. Carbon was founded by Longwood Fund and gene therapy pioneers, John F. Engelhardt, Ph.D., and Robert M. Kotin, Ph.D.
4
| Holding Company | Medical/Nursing Services | 4 |
Berwind LLC (Massachusetts)
 Berwind LLC (Massachusetts) Investment ManagersFinance Berwind LLC (Berwind) is a venture capital/private equity firm founded in 2000. The firm is headquartered in Harvard, Massachusetts.
1
| Private Company | Investment Managers | 1 |
Trefoil Therapeutics, Inc.
 Trefoil Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trefoil Therapeutics, Inc. operates as a biotechnology company. The firm develops applications for the eFGFs include regenerative therapies that may address a broad range of ischemic disease, including coronary heart disease, diabetic ulcers, and peripheral artery disease. The company was founded by Ralph Bradshaw, Ken Thomas and Michael Blaber in 2013 and is headquartered in San Diego, CA.
1
| Holding Company | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Derek Yoon via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| NEVRO CORP. | Medical Specialties | Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member Chief Executive Officer Sales & Marketing Sales & Marketing | |
| Bentley University | College/University | Undergraduate Degree Graduate Degree Masters Business Admin Undergraduate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| NKARTA, INC. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
| Yonsei University | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| The Johns Hopkins University | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| ALLERGAN, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
| PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| GENOCEA BIOSCIENCES, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Vaneltix Pharma, Inc.
 Vaneltix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Urigen Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on the development and commercialization of innovative products for urology indications. It is specialized in the design and implementation of products for patients with urological ailments, including products for amelioration of bladder pain syndrome and interstitial cystitis. The company was founded in March 1999 and is headquartered in North Brunswick, NJ. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| AERIE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
Cempra Pharmaceuticals, Inc.
 Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | Biotechnology | Founder Director/Board Member | |
Novo Ventures (US), Inc.
 Novo Ventures (US), Inc. Investment ManagersFinance Novo Ventures (US), Inc. is a venture capital firm located in San Francisco. The firm is a subsidiary of Novo A/S and their ultimate parent is Novo Nordisk Fonden. | Investment Managers | Private Equity Investor Private Equity Analyst | |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Medical Specialties | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| University of California, Berkeley | College/University | Undergraduate Degree Masters Business Admin | |
| PRECISION BIOSCIENCES, INC. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Doctorate Degree | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Doctorate Degree | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Investor Relations Contact | |
| New York University | College/University | Masters Business Admin Masters Business Admin | |
Ray Therapeutics, Inc.
 Ray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Ray Therapeutics, Inc. is an American company that is developing a lead candidate, RTX-015, to treat retinitis pigmentosa, a degenerative retinal disease. Ray Therapeutics is based in an undisclosed location. The company's mission is to restore vision for people with retinal degeneration using optogenetics gene therapies. Ray Therapeutics is pursuing multiple drug development programs for a range of degenerative retinal diseases, focusing on preserving and restoring vision in patients using the ground-breaking science of optogenetics. The company was founded by Paul Bresge and Sean Ainsworth, with Paul Bresge serving as CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Seoul National University | College/University | Undergraduate Degree Undergraduate Degree | |
| VOR BIOPHARMA INC. | Biotechnology | Director/Board Member Director/Board Member | |
TheraVida, Inc.
 TheraVida, Inc. Pharmaceuticals: MajorHealth Technology TheraVida, Inc. develops and commercializes therapeutic products that improve the lives of patients. The firm's products help to treatment of overactive bladder and urge urinary incontinence. It develops a portfolio of combination pharmaceutical products in the fields of urology and central nervous system disorders. The company was founded by Mehdi Paborji in 2005 and is headquartered in Chapel Hill, NC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
| CITIZENS FINANCIAL GROUP, INC. | Major Banks | Director/Board Member Chief Executive Officer | |
| AJU IB INVESTMENT CO., LTD. | Investment Managers | Director/Board Member Chief Executive Officer | |
Arch Oncology, Inc.
 Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Pharmaceuticals: Generic | Director/Board Member | |
| Clearview Projects, Inc. | Director/Board Member | ||
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Corporate Officer/Principal | |
| University of Dayton | College/University | Masters Business Admin | |
| RENEURON GROUP PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Cornerstone Pharmaceuticals, Inc.
 Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Second Genome, Inc.
 Second Genome, Inc. BiotechnologyHealth Technology Second Genome, Inc. develops microbiome-based therapeutic products. It offers phyclochip community, 16S sequencing community analysis, whole metagenomic profiling, nucleic acid isolation, inferred function and custom informatics services. The company was founded in 2009 by Corey S. Goodman, Janet A. Warrington, Todd Z. DeSantis, John Hulls and Gary Andersen and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
| G1 THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
BMO Capital Markets Corp. (Broker)
 BMO Capital Markets Corp. (Broker) Investment Banks/BrokersFinance BMO Capital Markets Corp. (Broker) is the broker/dealer division of BMO Capital Markets Corp., a full-service North American financial services provider headquartered in New York City. The firm was founded in 1998 and is a subsidiary of BMO Financial Corp., which is owned by Bank of Montreal (NYSE, TSX: BMO) in Canada. BMO Capital Markets offers corporate, institutional and government clients access to a variety of products and services including equity and debt underwriting, corporate lending and project financing, merger and acquisitions advisory services, merchant banking, securitization, treasury and market risk management, debt and equity research and institutional sales and trading. | Investment Banks/Brokers | Analyst-Equity | |
BNP Paribas Securities Corp.
 BNP Paribas Securities Corp. Investment Banks/BrokersFinance BNP Paribas Securities Corp. engages in the provision of brokerage services. It offers commercial banking, corporate and institutional banking, asset management, fleet services, and real estate. The company was founded on September 7, 1984 and is headquartered New York, NY. | Investment Banks/Brokers | Corporate Officer/Principal | |
| APELLIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Columbia Business School | College/University | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 46 |
| Zuid-Korea | 4 |
| Frankrijk | 2 |
| Verenigd Koninkrijk | 2 |
Sectoraal
| Health Technology | 24 |
| Consumer Services | 14 |
| Finance | 11 |
| Commercial Services | 4 |
Operationeel
| Director/Board Member | 242 |
| Corporate Officer/Principal | 83 |
| Private Equity Investor | 54 |
| Independent Dir/Board Member | 52 |
| Undergraduate Degree | 48 |
Sterkste connecties
| Insiders | |
|---|---|
| Ali Behbahani | 34 |
| Geeta S. Vemuri | 33 |
| Bruce van Saun | 32 |
| Kavita Patel | 30 |
| Tiba Aynechi | 24 |
| David Steinberg | 24 |
| Lewis Williams | 23 |
| Chen Schor | 23 |
| Marita Zuraitis | 21 |
| David Lubner | 19 |
| Jill Carroll | 19 |
| Benjamin McGraw | 16 |
| Rami Elghandour | 15 |
| George Lasezkay | 14 |
| Richard Croarkin | 13 |
- Beurs
- Insiders
- Derek Yoon
- Bedrijfsconnecties
